- Home
- DERM
as 11-18-2025 3:38pm EST
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | SCOTTSDALE |
| Market Cap: | 213.6M | IPO Year: | 2021 |
| Target Price: | $12.67 | AVG Volume (30 days): | 256.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.54 - $9.40 | Next Earning Date: | 11-12-2025 |
| Revenue: | $59,399,000 | Revenue Growth: | 2.82% |
| Revenue Growth (this year): | 26.16% | Revenue Growth (next year): | 45.27% |
Latest Journey Medical Corporation News
DERM Breaking Stock News: Dive into DERM Ticker-Specific Updates for Smart Investing
Zacks
6 days ago
Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics
Zacks
6 days ago
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates
GlobeNewswire
6 days ago
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
GuruFocus.com
8 days ago
What To Expect From Journey Medical Corp (DERM) Q3 2025 Earnings
Zacks
13 days ago
electroCore, Inc. (ECOR) Reports Q3 Loss, Beats Revenue Estimates
GlobeNewswire
14 days ago
Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
Zacks
14 days ago
OmniAb, Inc. (OABI) Reports Q3 Loss, Misses Revenue Estimates
GlobeNewswire
a month ago
Journey Medical Corporation to Participate in October 2025 Investor Conferences
Compare DERM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DERM Journey Medical Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.